|
Molecular profiles and treatment recommendations for invasive lobular carcinoma in a real-world prospective breast cancer registry. |
|
|
Research Funding - Agendia (Inst); Seagen (Inst) |
Travel, Accommodations, Expenses - Agendia |
|
|
No Relationships to Disclose |
|
|
Speakers' Bureau - EUSA Pharma; Foundation Medicine; Johnson & Johnson; Takeda |
|
|
|
|
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Patents, Royalties, Other Intellectual Property - NXT Biologics |
|
|
|
Stock and Other Ownership Interests - Agendia |
Travel, Accommodations, Expenses - Agendia |
|
|
No Relationships to Disclose |